Storys zum Thema Enterprises

07.05.2008 – 13:43
Astellas Pharma Europe Limited
Astellas' Mycamine(R) (micafungin) Licensed for Use in Europe to Treat Serious Fungal Infections
Staines, England (ots/PRNewswire) - The European Medicines Agency (EMEA) has announced the marketing authorisation of Mycamine(R), Astellas Pharma Europe's treatment for invasive candidiasis, oesophageal candidiasis and prophylaxis of Candida infection in patients undergoing allogeneic haematopoietic stem cell transplantation. Mycamine(R) will initially be available ...
mehr
07.05.2008 – 13:38
Boehringer Ingelheim
Women Suffering From Decreased Sexual Desire: Silence Hinders Diagnosis of the Prevalent Condition Hypoactive Sexual Desire Disorder (HSDD)
Ingelheim, Germany (ots/PRNewswire) - - For Non-US Media - Boehringer Ingelheim Announces Commitment to Progressing Science in This Area of Unmet Medical Need With the 'Bouquet' Studies. Data announced at this week's American College of Obstetricians and Gynecologists (ACOG) annual clinical meeting ...
mehr
07.05.2008 – 13:03
ICS Copper Systems Ltd
Installation of EMEW Plant in Zambia by Q4 of 2008 - On Schedule
Abbotsford, Canada (ots/PRNewswire) - ICS Copper Systems Ltd. (ICX:TSX.V) is pleased to announce that the company is on track to complete the installation of its EMEW plant by Q4 of 2008 at the Mokambo site in Mufulira, Zambia. The plant is designed to produce approximately 600 tonnes of finished copper and approximately 100 tonnes of cobalt carbonate annually. The Company will initially be processing third party ...
mehr
06.05.2008 – 14:41
AstraZeneca GmbH
The American Psychiatric Association's Awards for Young Scientists Encourage Research Expertise in China
Washington, Dc (ots/PRNewswire) - - International Reach of 'Young Minds in Psychiatry' Awards is Boosted With AstraZeneca Support For the first time, a researcher from China has received one of the American Psychiatric Association's (APA) prestigious "Young Minds in Psychiatry" awards, which were ...
mehr
06.05.2008 – 14:30
European Capital
European Capital Invests Euro 28 Million in International Electronics and Engineering
St. Peter Port, Guernsey (ots/PRNewswire) - ECAS S.a.r.l, an indirect wholly-owned subsidiary of European Capital Limited (LSE: ECAS) ("European Capital"), announced today that it has invested euro 28 million in International Electronics and Engineering S.A. ("IEE"), a leading and innovative developer of safety-critical sensing solutions for the automotive ...
mehr
06.05.2008 – 14:13
Atmel Corporation
Atmel Introduces an AVR USB 2.4GHz Wireless Reference Design for Battery-Based PC Peripherals
San Jose, California (ots/PRNewswire) - Atmel(R) Corporation (Nasdaq: ATML), announced today the AVRUSBRF01 reference design for development with AVR(R) microcontrollers in the un-licensed 2.4 GHz ISM band and connection to PCs with USB. USB is the standard interface for connecting PC peripherals but wireless is becoming increasingly popular for peripherals ...
mehr

06.05.2008 – 10:03
AAIR (Asthma, Allergy & Inflammation Research)
Making a Real Difference to the Lives of Asthma Patients
Southampton, England (ots/PRNewswire) - - Leading Asthma Expert Calls for Action On the occasion of World Asthma Day on 6 May, leading asthma expert Professor Stephen Holgate from the University of Southampton (UK) says: "I am delighted that the theme of this year's World Asthma Day 'You Can Control Your Asthma' sends out such a positive message. Indeed, with personalised disease management asthma can be ...
mehr
05.05.2008 – 14:11
BCS Global
Clive Sawkins is Promoted to Chief Executive Officer of BCS Global
London (ots/PRNewswire) - BCS Global Networks is pleased to announce that Clive Sawkins has accepted the position as Chief Executive Officer of the company. BCS is a managed service provider enabling video conferencing and visual collaboration globally. With its global video infrastructure, BCS provides its customers with an easy to use; direct connect, visual link to customers, colleagues and experts around the ...
mehr
02.05.2008 – 17:26
European Capital Financial Services Limited
European Capital Announces Departure of UK Managing Director
St. Peter Port, Guernsey (ots/PRNewswire) - European Capital Financial Services Limited ("European Capital"), the sub-investment manager of European Capital Limited (LSE: ECAS), announced the departure of Simon Henderson, Managing Director, UK Buyouts, effective May 1. Mr. Henderson is leaving the firm to pursue time with his family. "We thank Simon for his efforts on behalf of European Capital and we wish him ...
mehr
02.05.2008 – 14:06
Atmel Corporation
Atmel Receives Frost & Sullivan's Technology Innovation Award for FingerChip(R) Biometric Sensor
San Jose, California (ots/PRNewswire) - Atmel(R) Corporation (Nasdaq: ATML) was recently recognized for its development of the FingerChip(R) fingerprint sensor technology at the 2008 Frost & Sullivan Southeast Asia Industrial Technologies awards presentation in Kuala Lumpur, Malaysia. Mr. Yang Chiah Yee, Vice President of Asian Sales for Atmel, accepted the ...
mehr
01.05.2008 – 20:24
European Capital
European Capital Invests Euro 142 Million and Supports Growth in Buyout Investments in Q1 2008
St. Peter Port, Guernsey (ots/PRNewswire) - European Capital Limited (LSE: ECAS) ("European Capital"), announced that in the first quarter of 2008 it supported the growth of its portfolio companies through four add-on acquisitions: -- Wakame: Add-on to Marco Polo Foods, European manufacturer of fresh and frozen sushi, completed in January. European ...
mehr
01.05.2008 – 13:17
Servier
Coversyl(R) Protects Hypertensive Patients Against New-Onset Diabetes
Paris (ots/PRNewswire) - - New Analysis of ASCOT-BPLA Data Identifies Major Predictors of NOD Among Hypertensives A new analysis of data from the landmark Anglo-Scandinavian Cardiac Outcomes Trial - Blood Pressure Lowering Arm (ASCOT-BPLA) published today in Diabetes Care has identified the major predictors of new-onset diabetes (NOD) in patients with ...
mehr

30.04.2008 – 19:02
International Seabed Authority Company
Endowment Fund Makes For Strange Seabed-Fellows
New York (ots/PRNewswire) - Environmental, commercial mining and scientific interests in deep-sea areas may seem to be at odds, but the International Seabed Authority's Endowment Fund shows the alliance as a successful model for sustainable use of ocean resources. "Technological advancements and the rising price of minerals have created favourable economic conditions for seabed mining," said Mr. Satya Nandan, ...
mehr
30.04.2008 – 13:05
SemBioSys, Genetics Inc
Botaneco Signs Feasibility Agreement With Croda to Develop Specialty Crop Oil Formulation
Calgary, Canada (ots/PRNewswire) - - Program Will Focus on Evaluation of Botaneco's Technology to add Functionality to Echium oil Botaneco, a wholly-owned subsidiary of SemBioSys Genetics Inc., today announced that it has signed a feasibility agreement with Croda Enterprise Technology, part of Croda International Plc, an international manufacturer of ...
mehr
29.04.2008 – 13:57
Boehringer Ingelheim
Journalist Invitation - International Media Webcast
Ingelheim, Germany (ots/PRNewswire) - The science of sexual desire No doubt you've written about it before: Sex - an ever-present topic in newspapers and magazines. Yet, despite the genuine interest in sex, little focus is given to the science behind it and even less so when it comes to female sexual dysfunction, the most common type being Hypoactive Sexual Desire Disorder (HSDD). Up to one in ten women ...
mehr
29.04.2008 – 13:27
Hopital Laval
Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat
Quebec City, Canada (ots/PRNewswire) - At a late breaking presentation made on April 29th during the Annual meeting of the European Atherosclerosis Society held in Istanbul, the investigators of ADAGIO-LIPIDS presented the key findings of a one year trial aiming at further studying the effects of rimonabant on ...
mehr
28.04.2008 – 15:19
Wyn Developments Inc.
Wyn Developments Appoints Kesonen, Timcke, Danielsson, Klassen, Robson and Espadilla to Wyn Metals Management Team
Vancouver, Canada (ots/PRNewswire) - Wyn Developments Inc. (the "Company" or "Wyn") announces Daniel Kesonen , Rick Timcke, Pieter Danielsson, Ian Klassen, Craig Robson and Dennis Espadilla have agreed to become Wyn Metals Inc ("Wyn Metals") new management team and lead the company upon shareholder approval of ...
mehr
26.04.2008 – 18:39
Roche Pharmaceuticals
Three Studies Presented at 43rd EASL Strongly Indicate Better Efficacy for PEGASYS in Curing Hepatitis C
Basel, Switzerland (ots/PRNewswire) - - Roche Also Provides Comment on Results of "IDEAL" Trial Roche today announced that compelling new data from three studies indicate that chronic hepatitis C patients who received PEGASYS(R) (peginterferon alfa-2a) plus COPEGUS(R) (ribavirin) had a greater chance of ...
mehr

26.04.2008 – 18:17
Roche Pharmaceuticals
Roche's R1626, First-in-Class Hepatitis C Polymerase Inhibitor, Demonstrates Impressive End-of-Treatment Response in Phase IIa Study
Basel, Switzerland (ots/PRNewswire) - - R1626 Also Shows a High Barrier to the Development of Resistance Roche's investigational treatment for hepatitis C, R1626, has shown an impressive end-of-treatment response rate when given in combination with PEGASYS(R) (peginterferon alfa-2a) and ...
mehr
26.04.2008 – 09:17
Roche Pharmaceuticals
New Pegasys Data Show Hepatitis B Patients Achieve Highly Positive Treatment Response That Comes as Close to a Cure as Possible
Basel, Switzerland (ots/PRNewswire) - - No Nucleoside/Nucleotide Analogue Treatments Have Shown Similar Results New data revealed today show that a significant number of patients with chronic hepatitis B virus infection who received PEGASYS(R) (peginterferon alfa-2a) treatment achieved clearance of ...
mehr
25.04.2008 – 16:33
Boehringer Ingelheim
Data Suggests Promising Overall Survival and Progression-Free Survival With VARGATEF(TM) (BIBF 1120)
Ingelheim, Germany (ots/PRNewswire) - - For non-US Healthcare Media - Abstract # 163O. von Pawel. Proffered Papers 6 - Advanced NSCLC - Latest Phase II Data for Boehringer Ingelheim's New Cancer Drug in Development Presented Monotherapy treatment with the triple angiokinase inhibitor(1) BIBF 1120 ...
mehr
25.04.2008 – 07:03
Valeo Management Services
Valeo: 30% Increase in Net Income in the First Quarter 2008
Paris (ots/PRNewswire) - - Third consecutive Quarter of Improved Margins - Continued Refocusing of the Product Portfolio Following the meeting of its Board of Directors, Valeo presented its first quarter 2008 results. (in EUR million) 1 January - 31 March 2008* 2007** change Total operating revenues 2,473 2,499 ...
mehr
24.04.2008 – 22:15
Wyeth Pharmaceuticals
Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
COLLEGEVILLE, Pennsylvania and TARRYTOWN, New York, April 24 (ots/PRNewswire) -- - Final Decision from European Commission Expected by Mid-2008 Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), today announced that the companies have received a ...
mehr
24.04.2008 – 11:43
Wyeth Pharmaceuticals
DART Study Results Demonstrate Dose Escalation With Enbrel(R)(etanercept) is Significantly Lower Than Other Commonly Used Anti-TNF Agents in Patients With Rheumatoid Arthritis(1)
Liverpool, England (ots/PRNewswire) - - Irrespective of Budgetary Restrictions, etanercept Dose Escalation Remains Low Suggesting etanercept Achieves Sustained Efficacy and is a Cost Effective Treatment for Rheumatoid Arthritis New pan-European data presented today at the British Society of Rheumatology's ...
mehr

24.04.2008 – 00:06
Wyeth Pharmaceuticals
More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL
Collegeville, Pennsylvania (ots/PRNewswire) - - Wyeth Withdraws European Application Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that it is withdrawing its application for an extension to the European Marketing Authorization for TYGACIL(R) (tigecycline). This extension sought approval of TYGACIL for the treatment ...
mehr
22.04.2008 – 15:36
Resverlogix Corp.
Dosing for RVX-208 Phase 1a Clinical Study Completed
Calgary, Canada (ots/PRNewswire) - - Phase 1a Study Objectives Were Met - TSX Exchange Symbol: RVX Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has completed dosing of its Phase 1a safety, tolerability and pharmacokinetics study for its lead drug candidate, RVX-208, which addresses the dyslipidemia market. "Initial results from the emerging data are very good," ...
mehr
22.04.2008 – 14:03
Atmel Corporation
Atmel Unveils Industry's First Off-the-Shelf LF Antenna Driver IC for Passive Entry Go/Passive Go Systems
Heilbronn, Germany (ots/PRNewswire) - Atmel(R) Corporation (Nasdaq: ATML) announced today the availability of the new LF coil driver IC ATA5279 designed for Passive Entry Go (PEG) and Passive Go (PG) hands-free car access systems. This is industry's first and only off-the-shelf antenna driver IC. Compared to ...
mehr
21.04.2008 – 14:08
Atmel Corporation
Atmel's CAP Customizable Microcontroller Named 2007 Product of the Year by EPC Magazine
Rousset, France (ots/PRNewswire) - - One of Leading Products Selected by Editors and Industry Experts Atmel(R) Corporation (Nasdaq: ATML) announced today that its CAP(TM) customizable microcontroller has been named as one of the Products of the Year by Electronic Products China (EPC) Magazine. The selection was made by a panel of editors and industry experts ...
mehr
18.04.2008 – 19:11
Valeo Management Services
Valeo Lighting Systems in Spain Wins Prestigious Prince Felipe Award for Business Competitiveness
Paris (ots/PRNewswire) - Valeo Lighting Systems' Martos plant in Spain has won the Prince Felipe Award for Business Competitiveness, the highest distinction given to a company in Spain. "It is an honor for Valeo to receive this prestigious award highlighting the importance of quality, innovation and operational excellence, which are at the heart of our Group's ...
mehr
18.04.2008 – 12:09
Roche Pharmaceuticals
Herceptin(R) Helps Eradicate HER2-Positive Breast Tumours When Given Before Surgery
BERLIN - European Breast Cancer Conference (EBCC), April 18 (ots/PRNewswire) -- - For Non-UK and Non-US Media Only - Herceptin Offers Women With HER2-Positive Breast Cancer the Best Chance of a Cure New data presented today as part of a late breaking plenary session at EBCC in Berlin showed that Herceptin (trastuzumab) in combination with standard ...
mehr

Vorherige70717273747576777879Nächste